Examkin

Question

Difficulty: HardReproductive Endocrinology and Infertility

A 15-year-old girl is brought to the clinic by her mother for evaluation of absent menstrual periods. She has never menstruated. Physical examination reveals a height at the 5th percentile for age, Tanner stage 1 breast development, and normal-appearing female external genitalia with a patent vagina. A urine pregnancy test is negative. Arrange the following diagnostic and management actions in the most appropriate sequential order according to the standard algorithmic approach for primary amenorrhea.

  1. 1Perform a pelvic ultrasonography to confirm the presence of a uterus
  2. 2Measure serum follicle-stimulating hormone (FSH) to evaluate the hypothalamic-pituitary-ovarian axis
  3. 3Obtain a peripheral blood karyotype to evaluate for chromosomal aneuploidy
  4. 4Perform a baseline transthoracic echocardiogram to screen for associated structural anomalies
  5. 5Initiate low-dose transdermal estrogen therapy for pubertal induction

Answer

The correct sequence is: Pelvic ultrasonography, followed by Serum FSH measurement, followed by Karyotype analysis, followed by Transthoracic echocardiogram, and finally Initiation of estrogen therapy.
The standard diagnostic ladder for primary amenorrhea begins with a physical exam and ultrasound to verify the presence of a uterus. If a uterus is present but breast development is absent, the patient is hypoestrogenic, prompting FSH measurement. Elevated FSH signifies primary ovarian insufficiency. In a short-statured teenager, this is highly suspicious for Turner syndrome, prompting a karyotype. Once Turner syndrome is confirmed, cardiovascular screening (echocardiogram) is mandatory before establishing long-term care. Finally, hormone replacement (estrogen) is initiated to induce puberty and prevent osteoporosis.

Step-by-Step Solution

1
Pelvic ultrasonography
Confirms the presence of normal internal Müllerian structures.
In any patient presenting with primary amenorrhea, establishing the anatomical presence of a uterus is the foundational step before initiating biochemical workup, ruling out Müllerian agenesis or androgen insensitivity syndrome.
2
Serum FSH measurement
Differentiates central from peripheral etiology based on estrogen deficiency.
Because the patient has Tanner stage 1 breast development, she lacks endogenous estrogen. FSH distinguishes between ovarian failure (high FSH) and a hypothalamic/pituitary defect (low/normal FSH).
3
Karyotype analysis
Provides the definitive genetic diagnosis of gonadal dysgenesis.
Assuming hypergonadotropic hypogonadism (elevated FSH) given the clinical presentation of short stature, a karyotype is required to diagnose Turner syndrome (45,X) and determine if Y chromosome material is present (which would necessitate gonadectomy).
4
Transthoracic echocardiogram
Screens for critical, life-threatening congenital heart defects.
All patients newly diagnosed with Turner syndrome must undergo comprehensive cardiovascular screening, as aortic root dilation, bicuspid aortic valve, and aortic coarctation are a major source of morbidity and mortality.
5
Estrogen therapy initiation
Induces secondary sexual characteristics and protects bone health.
Once the diagnosis is secured and associated risks are evaluated, the long-term management of hypergonadotropic hypogonadism involves estrogen replacement to mimic natural puberty, followed eventually by progestin to protect the endometrium.

Key Concept

The algorithmic evaluation of primary amenorrhea requires establishing anatomy (ultrasound) followed by biochemical axis testing (FSH), and finally genetic testing (karyotype) for hypergonadotropic states prior to initiating long-term management.
Rate this question

Topics

Reproductive Endocrinology and Infertility

More questions from this topic